While obesity and diabetes are not typical features of TTC21B mutation, a murine model showed that TTC21B/IFT139 knockout mice developed hyperphagic behavior and obesity, resulting in type II diabetes mellitus and fatty liver disease (2). This evidence concerns the gene TTC21B and obesity due to melanocortin 4 receptor deficiency.